12月5日，宁波健信超导科技股份有限公司（股票简称：健信超导，股票代码：688805）正式披露招股意向书等公告，将在上交所科创板挂牌上市。健信超 导首次公开发行股票不超过4，192.00万股，不低于发行后总股本的25%，发行后总股本不超过16，768.00万股，保荐机构为广发证券。 健信超导初步询价日为12月10日，网上路演日为12月12日，网上、网下申购日为12月15日，网上、网下缴款日为12月17日。本次IPO募集资金将投向年产 600套无液氦超导磁体项目、年产600套高场强医用超导磁体技改项目和新型超导磁体研发项目。 健信超导持续进行研发投入，截至2025年6月30日，拥有授权专利共计85项，其中发明专利45项。公司分别于2023年入选国家专精特新"小巨人"企业、于 2024年入选国家专精特新重点"小巨人"企业。公司设有浙江省高新技术企业研究开发中心、浙江省博士后工作站、院士工作站，已完成宁波市科技创新2025 重大专项"无液氦超导磁体的研发"项目，参与完成工信部医疗器械材料生产应用示范平台项目并具体负责"无液氦超导磁体生产应用示范线、无液氦超导磁 体测试评价和考核验证能力"，报告期内参与科技部国家重点 ...

在美国一家研究中心驳斥了近期有关韩国在超导技术上取得突破的说法后，被认为与超导相关的韩国股 票抹去涨幅，周二尾盘下跌。 "我们深感悲痛，现在认为这件事已经结束了。LK-99不是超导体，"马里兰州大学凝聚态理论中心在社 交媒体平台X（原名推特）上表示，"这是一种电阻极高的劣质材料。" 另外，韩国金融监督院院长对该题材部分股份近期过度飙升和保证金交易增加表示担忧。 Sunam Co．跌到30%的跌停板，早前一度上涨22%； Duksung收盘下跌29%，之前一度上涨24%； Mobiis下跌26%，之前一度上涨22%； Shinsung Delta Tech收低6.5%，之前一度上涨30%而涨停； ...

Core Viewpoint - The company, GuoDun Quantum, is actively engaged in the development of quantum computing technology, focusing on superconducting technology and collaborating with research institutions to enhance its capabilities in this field [1] Group 1: Quantum Computing Development - The company has established horizontal collaborations with research institutions such as the University of Science and Technology of China to develop quantum computing chips [1] - GuoDun Quantum offers complete quantum computing solutions beyond just chips, including measurement and control systems, dilution refrigerators, and other core components [1] - The company is committed to core technology breakthroughs and product development through self-research and partnerships with leading research teams [1] Group 2: Market Positioning - The company has successfully delivered products to downstream research and industrial clients, indicating its active role in the market [1] - The focus on superconducting technology positions the company strategically within the quantum computing industry [1]

Group 1 - The core point of the article is the approval by the China Securities Regulatory Commission for Ningbo Jianxin Superconducting Technology Co., Ltd. to conduct its initial public offering (IPO) on the Shanghai Stock Exchange, with a fundraising target of 865 million yuan [1] - Jianxin Superconducting primarily engages in the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, including superconducting magnets, permanent magnets, and gradient coils [1] - The company has developed a diverse product matrix in the superconducting field, including 1.5T zero-evaporation superconducting magnets, 1.5T liquid helium-free superconducting magnets, 3.0T zero-evaporation superconducting magnets, and open zero-evaporation superconducting magnets, making it the leading independent supplier of superconducting magnets in the global MRI industry [1]

Core Insights - The company reported Q2 2025 revenue of approximately $66 million, a year-over-year increase of over 20%, although slightly below analyst expectations of $67.85 million [1] - Net profit under GAAP was $4.8 million, translating to earnings per share of $0.11, a slight decrease from $4.9 million ($0.13 per share) in the same quarter of the previous fiscal year [1] - Non-GAAP net profit reached $8.9 million, corresponding to earnings per share of $0.20, down from $10 million ($0.27 per share) year-over-year, primarily due to costs associated with the acquisition of NWL Inc. [1] - This performance marks the fifth consecutive quarter of profitability for the company, breaking a streak of losses from 2011 to 2024, with 2025 expected to be the first profitable year since 2010 [1] Financial Performance - The gross margin exceeded 30%, with a gross profit of $20.4 million on revenues of $65.9 million, indicating an optimized cost structure as revenue scales up [2] - The grid business was the main growth driver, contributing $54.34 million in revenue, while the wind power segment added $11.52 million [2] - Free cash flow for the quarter was $5.4 million, with operating cash flow reaching $10.6 million, and cash and cash equivalents increased to $218.8 million from $85.4 million as of March 31, 2025, strengthening the balance sheet for future investments or acquisitions [2] Management Commentary - The CEO expressed confidence in the company's performance, citing strong demand in the energy and military markets, driven by the robust growth of U.S. manufacturing and the urgent need for reliable power in key industries [2] Future Outlook - For Q3 2025, the company expects revenue to be between $65 million and $70 million, with GAAP net profit anticipated to exceed $2 million ($0.05 per share) and Non-GAAP net profit expected to exceed $6 million ($0.14 per share) [2] Market Reaction - Prior to the earnings release, the company's stock rose by 5.56% to $59.42, reflecting investor confidence in the turnaround from years of losses; however, the stock fell over 20% in after-hours trading [3]

Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has been approved for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board, marking a significant milestone for the company in the medical imaging sector [1] Company Overview - Jianxin Superconducting focuses on the research and production of core components for medical magnetic resonance imaging (MRI), establishing a product matrix that covers both "superconducting + permanent magnet" technologies and mainstream field strengths of "1.5T-3.0T" [1] - The company has become a leading independent supplier of superconducting magnets globally and the largest supplier of permanent magnets for MRI equipment, supporting the upgrade of domestic MRI devices from "usable" to "high-quality" [1] Technological Advancements - In the high-field superconducting magnet sector (1.5T and above), Jianxin Superconducting is one of the earliest manufacturers in China to achieve large-scale production [1] - The company has developed core technologies such as electromagnetic field design, ultra-low temperature technology, and magnet stability control through independent research and development [1] - Jianxin Superconducting has achieved mass supply of zero-evaporation superconducting magnets, significantly enhancing the localization rate of MRI equipment and making a critical breakthrough in entering the supply chain of leading complete machine enterprises [1] Product Offerings - The company can provide over 30 types of permanent magnets and matching gradient coils with magnetic field strengths ranging from 0.08T to 0.5T [1]

Core Viewpoint - Ningbo Jianxin Superconductor Technology Co., Ltd. has successfully passed the IPO review for the Sci-Tech Innovation Board, positioning itself as the world's largest independent supplier of superconducting magnets for MRI equipment [1][2] Group 1: Company Overview - Jianxin Superconductor's IPO application was approved on October 21, with its review status updated to "submitted for registration" [1] - The company ranks fifth globally and second domestically in terms of market share for superconducting magnets used in MRI equipment, based on installed capacity [1] Group 2: Market Position and Technology - The company has closed a 20-year technology gap with international giants in the field of zero-evaporation superconducting technology, enhancing product performance and cost competitiveness through design and process innovation [2] - Jianxin Superconductor is one of the earliest manufacturers in China to scale up the production of high-field superconducting magnets, breaking the long-standing monopoly of European and Japanese manufacturers since 2015 [2] Group 3: Financial Performance - The company's revenue for the years 2022 to 2024 and the first half of 2025 is as follows: - 2022: 35.89 million yuan - 2023: 45.06 million yuan - 2024: 42.55 million yuan - 2025 (first half): 25.21 million yuan [2] - Net profit figures for the same periods are: - 2022: 3.46 million yuan - 2023: 4.87 million yuan - 2024: 5.58 million yuan - 2025 (first half): 3.19 million yuan [2] Group 4: Partnerships and Industry Impact - The company has established close partnerships with well-known MRI equipment manufacturers, including Fujifilm, GE Healthcare, and United Imaging Healthcare, contributing to the domestic MRI industry's core component supply [2]

Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has received approval for its IPO application on the Sci-Tech Innovation Board, with its review status updated to "submitted for registration" as of October 21 [1] Group 1: Market Position and Competitiveness - In terms of installed capacity, Jianxin Superconducting ranks fifth globally and second among domestic companies in the MRI superconducting magnet market for 2024, making it the largest independent supplier of superconducting magnets worldwide [1] - The company has established a comprehensive product matrix in the superconducting field, including 1.5T zero-evaporation superconducting magnets and 3.0T zero-evaporation superconducting magnets, becoming the top independent supplier in the global MRI industry [3] - Jianxin Superconducting has closed a 20-year technology gap with international giants in the zero-evaporation superconducting technology field and has continuously improved product performance and cost competitiveness through design and process innovation [3] Group 2: Financial Performance - The company's revenue for the periods from 2022 to 2024 and the first half of 2025 are as follows: 358.93 million yuan, 450.64 million yuan, 425.50 million yuan, and 252.10 million yuan respectively [4] - The net profit for the same periods is reported as 34.63 million yuan, 48.73 million yuan, 55.78 million yuan, and 31.92 million yuan respectively [4] Group 3: Strategic Partnerships - Jianxin Superconducting has established close cooperative relationships with well-known MRI equipment manufacturers both domestically and internationally, including Fujifilm Holdings, GE Healthcare, and United Imaging Healthcare [3]

Group 1: Company Overview - Ningbo Jianxin Superconducting Technology Co., Ltd. (referred to as "Jianxin Superconducting") is preparing for its IPO review on the Sci-Tech Innovation Board, focusing on the R&D, production, and sales of core components for MRI equipment [1] - The company is one of the earliest manufacturers in China to scale the production of high-field superconducting magnets, breaking the long-standing monopoly of foreign manufacturers in the 1.5T superconducting magnet sector since 2015 [1][4] - Jianxin Superconducting has established itself as the largest independent supplier of superconducting magnets globally, with a projected global market share ranking of fifth and second among domestic companies in 2024 [1][6] Group 2: Market Dynamics - The global MRI equipment market is expected to grow from $11.1 billion in 2024 to $14.89 billion by 2030, with a compound annual growth rate (CAGR) of approximately 5.0% [2] - The Chinese MRI equipment market has seen growth from 10.45 billion yuan in 2015 to 16.6 billion yuan in 2024, with an anticipated CAGR of 5.3%, further projected to reach 22.76 billion yuan by 2030 [2] - Superconducting MRI devices are the mainstream type in the domestic market, expected to account for over 90% of the total installed capacity in 2024 [2] Group 3: Policy and Technological Support - Recent national policies have supported the development of medical equipment, particularly encouraging innovation in domestic medical devices and focusing on core components as key areas for advancement [3] - The MRI equipment market is experiencing a favorable development phase driven by demand growth, policy encouragement, and technological innovation [3] Group 4: Technological Advancements - Jianxin Superconducting has developed a comprehensive core technology system, including electromagnetic field design, cryogenic technology, finite element analysis, structural design, intelligent control technology, and manufacturing processes [4] - The company has achieved significant advancements in superconducting technology, including the development of a fully helium-free superconducting magnet, recognized as the "first of its kind" in 2021 [5] Group 5: Financial Performance and Growth - Jianxin Superconducting has established strong partnerships with notable MRI equipment manufacturers, contributing to stable product demand and a robust sales channel [7] - The company's revenue has shown a consistent upward trend from 359 million yuan in 2022 to 425 million yuan in the first half of 2025, with net profits also increasing during the same period [7] - The company aims to raise funds through its IPO to enhance R&D and product innovation, focusing on projects such as the annual production of 600 helium-free superconducting magnets [8]

Core Viewpoint - Yan Mountain Technology (002195) announced that its subsidiary Yan Chao Fusion has completed a multi-hundred million RMB angel round financing, aimed at advancing the research and development of fusion devices and superconducting technology applications [1] Financing and Investment - The financing round was co-led by Yan Mountain Technology and Yan Mountain Investment, with the funds designated for the development of advanced superconducting fusion devices [1] Technological Development - Yan Chao Fusion is focusing on an advanced superconducting fusion route, emphasizing its unique steady-state operation advantages and future grid compatibility [1] - The company is advancing the research of an advanced superconducting fusion system using internationally leading quasi-equilibrium magnetic configurations and leveraging AI and 3D printing to accelerate device development [1] Collaborative Efforts - The company is establishing a "Fusion and New Energy Joint Laboratory" in collaboration with Peking University in Shenzhen, focusing on the physics and engineering of fusion devices, AI for science, superconducting materials, and energy applications [1] - Yan Chao Fusion is actively expanding international research cooperation channels and plans to recruit globally recognized fusion experts to form a top-tier academic advisory committee [1]